Amarin Corporation PLC • AMRN

Capital at risk.

About Amarin Corporation PLC
Ticker
info
AMRN
Trading on
info
NASDAQ
ISIN
info
US0231112063
Industry
info
Drug Manufacturers - General
Sector
info
Healthcare
CEO
info
Aaron D. Berg
Headquarters
info
Iconic Offices, The Greenway, Dublin, undefined, Ireland, 112-114
Employees
info
275
Website
info
amarincorp.com
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Metrics
BasicAdvanced
Market cap
info
$190M
P/E ratio
info
-
EPS
info
-$0.20
Dividend Yield
info
0.00%
Beta
info
1.83
Forward P/E ratio
info
500
EBIDTA
info
$-52.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$190M
Average daily volume
info
2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
500
PEG ratio
info
-1.74
Trailing P/E
info
0
Price to sales
info
0.83
Price to book
info
0.39
Earnings
EPS
info
-$0.20
EPS estimate (current quarter)
info
-$0.03
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-52.3M
Revenues (TTM)
info
$229M
Revenues per share (TTM)
info
$0.56
Technicals
Beta
info
1.83
52-week High
info
$1.11
52-week Low
info
$0.35
50-day moving average
info
$0.53
200-day moving average
info
$0.59
Short ratio
info
5.81
Short %
info
2.65%
Management effectiveness
ROE (TTM)
info
15.83%
ROA (TTM)
info
4.56%
Profit margin
info
35.95%
Gross profit margin
info
$118M
Operating margin
info
25.76%
Growth
Quarterly earnings growth (YoY)
info
94.20%
Quarterly revenue growth (YoY)
info
16.60%
Share stats
Outstanding Shares
info
414M
Float
info
386M
Insiders %
info
1.63%
Institutions %
info
18.11%
Analyst Insights & forecasts
info

1% Buy

33% Hold

66% Sell

Based on information from 3 analysts.

Average price target

info
$1.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.02
-$0.03
33.33%
Q1 • 24Beat
$0.00
-$0.04
109.25%
Q2 • 24Beat
-$0.05
-$0.06
16.67%
Q3 • 24Beat
-$0.02
-$0.03
33.33%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$42.3M
$-25.1M
59.42%
Q3 • 24
$62.3M
$-48.6M
78.03%
Q4 • 24
47.30%
93.44%
31.32%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$751M
$219M
29.21%
Q3 • 24
$685M
$199M
29.06%
Q4 • 24
8.70%
9.15%
0.50%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2.4M
$-56.6M
$-0.1M
$-2.4M
Q3 • 24
$-13.3M
$-22.8M
$0M
$-13.3M
Q4 • 24
465.13%
59.61%
125.16%
463.98%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Amarin Corporation PLC share?
Collapse

Amarin Corporation PLC shares are currently traded for undefined per share.

How many shares does Amarin Corporation PLC have?
Collapse

Amarin Corporation PLC currently has 414M shares.

Does Amarin Corporation PLC pay dividends?
Collapse

No, Amarin Corporation PLC doesn't pay dividends.

What is Amarin Corporation PLC 52 week high?
Collapse

Amarin Corporation PLC 52 week high is $1.11.

What is Amarin Corporation PLC 52 week low?
Collapse

Amarin Corporation PLC 52 week low is $0.35.

What is the 200-day moving average of Amarin Corporation PLC?
Collapse

Amarin Corporation PLC 200-day moving average is $0.59.

Who is Amarin Corporation PLC CEO?
Collapse

The CEO of Amarin Corporation PLC is Aaron D. Berg.

How many employees Amarin Corporation PLC has?
Collapse

Amarin Corporation PLC has 275 employees.

What is the market cap of Amarin Corporation PLC?
Collapse

The market cap of Amarin Corporation PLC is $190M.

What is the P/E of Amarin Corporation PLC?
Collapse

The current P/E of Amarin Corporation PLC is null.

What is the EPS of Amarin Corporation PLC?
Collapse

The EPS of Amarin Corporation PLC is -$0.20.

What is the PEG Ratio of Amarin Corporation PLC?
Collapse

The PEG Ratio of Amarin Corporation PLC is -1.74.

What do analysts say about Amarin Corporation PLC?
Collapse

According to the analysts Amarin Corporation PLC is considered a sell.